Search - tctmd.com

Presenter: Peter Smits, A. J. van Boven, Mariano Valdes, Antonio Serra, Jean-Jacques Goy, V. Voudris, J. M. Vazquez, Ramiro Trillo, A.G. Vuillomenet, Ton Slagboom, Peter den Heijer

January 31, 2013

News Daily News

TCTMD’s Top 10 Most Popular News Stories for 2012

Jason Kahn

January 02, 2013

News Daily News

Real-World Equivalence Seen for Zotarolimus- and Everolimus-Eluting Stents

Caitlin E. Cox

December 26, 2012

News Daily News

Equivalencia en el Mundo Real Confirmada de los Stents liberadores de Zotarolimus y Everolimus

Caitlin E. Cox

December 26, 2012

Advertisement

Consensus Paper Details Link Between Platelet Reactivity and Ischemia, Bleeding

INFUSE-AMI: Thirty-Day Reduction in Infarct Size May Translate to 1-Year Benefit

SPIRIT Meta-analysis Confirms Overall Superiority of Xience over Taxus

NCDR Registries Give Nationwide Assessment of Cardiovascular Care

Contemporary ZES Perform Well in Treating In-Stent Restenosis

No Increased Mortality Risk for DES Patients with High Platelet Reactivity on Clopidogrel

First Patients Enrolled in REMEDEE Registry to Evaluate Long-Term Safety and Performance of OrbusNeich’s COMBO Dual Therapy Stent™ in Routine Practice

For Bifurcation Lesions in Coronary Arteries, Medtronic's Resolute Stent Delivers Strong Long-Term Results

NEXT Published: Biodegradable Polymer BES Shows Noninferiority to EES

TWENTE: Still Few Differences between ZES and EES at 2 Years

ACC/i2 2013: Controversy, Late Breaking Trial News Dominate Busy Meeting

With Medtronic Resolute Stent, Interrupting Dual Antiplatelet Therapy After One Month Showed No Increased Safety Risk in Robust Analysis

Is Nobori NEXT? Biodegradable-Polymer DES Noninferior to EES

Randomized Comparison of PtCr-EES vs CoCr-ZES in All-Comers Receiving PCI: The HOST-ASSURE Randomized Trial

Pair of Studies Show Positive Stent Results at ACC

DEFER-STEMI: Holding Off Stenting for Several Hours Improves Outcomes

COMPARE II – 1 Year Outcomes of a large randomized all-comers study

TCTMD’s Top 10 Most Popular News Stories for 2012

Real-World Equivalence Seen for Zotarolimus- and Everolimus-Eluting Stents

Equivalencia en el Mundo Real Confirmada de los Stents liberadores de Zotarolimus y Everolimus

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content